Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Non-Current Assets (2016 - 2020)

Historic Non-Current Assets for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $6.1 million.

  • Larimar Therapeutics' Non-Current Assets fell 3497.46% to $6.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $22.0 million, marking a year-over-year decrease of 226.53%. This contributed to the annual value of $451000.0 for FY2019, which is 439.81% up from last year.
  • As of Q3 2020, Larimar Therapeutics' Non-Current Assets stood at $6.1 million, which was down 3497.46% from $6.3 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Non-Current Assets ranged from a high of $9.9 million in Q2 2019 and a low of $432000.0 during Q4 2018
  • Moreover, its 5-year median value for Non-Current Assets was $1.2 million (2016), whereas its average is $2.9 million.
  • In the last 5 years, Larimar Therapeutics' Non-Current Assets plummeted by 4743.13% in 2017 and then skyrocketed by 188403.36% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Non-Current Assets (Quarter) stood at $722000.0 in 2016, then decreased by 18.98% to $585000.0 in 2017, then fell by 26.15% to $432000.0 in 2018, then rose by 4.4% to $451000.0 in 2019, then surged by 1261.64% to $6.1 million in 2020.
  • Its Non-Current Assets was $6.1 million in Q3 2020, compared to $6.3 million in Q2 2020 and $9.0 million in Q1 2020.